33 Results for "

TRAF2

" in MedChemExpress (MCE) Product Catalog:
Products (33)

33 Results for "TRAF2" in MCE Product Catalog:

111
111 Publications Verification
Cat. No.: HY-19696B
CAS No.: 117609-50-4
Synonyms: Tauroursodeoxycholic acid dihydrate; TUDCA dihydrate; UR 906 dihydrate
Tauroursodeoxycholate dehydrate is an orally active taurine conjugate of Ursodeoxycholic acid (HY-13771). Tauroursodeoxycholate dehydrate inhibits caspase-3/7, Apoptosis, IRE1α/TRAF2/NF-κB, prevents JNK phosphorylation, inhibits ROS generation, and activates Akt signaling. Tauroursodeoxycholate dehydrate prevents cataract formation, reduces renal tubular damage in type 2 diabetic mice, reduces I/R injury in liver, and inhibits intestinal inflammation and barrier disruption in nonalcoholic fatty liver disease [2] .
loading...
    loading...
44
44 Cited Publications
Cat. No.: HY-16591
CAS No.: 1260251-31-7
Synonyms: TL32711
Target:  

IAP Apoptosis HIV

Research Areas:  

Cancer

Birinapant (TL32711), a bivalent Smac mimetic, is a potent antagonist for XIAP and cIAP1 with Kds of 45 nM and less than 1 nM, respectively. Birinapant (TL32711) induces the autoubiquitylation and proteasomal degradation of cIAP1 and cIAP2 in intact cells, which results in formation of a RIPK1: caspase-8 complex, caspase-8 activation, and induction of tumor cell death. Birinapant (TL32711) targets TRAF2-associated cIAPs and abrogates TNF-induced NF-κB activation.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-100830
CAS No.: 1792999-26-8
Purity:  99.61%
Target:  

Wnt MAP4K TGF-beta/Smad

Research Areas:  

Cancer

NCB-0846 is an orally active, selective inhibitor for Wnt, that inhibits Traf2- and Nck-interacting kinase (TNIK) with an IC50 of 21 nM. NCB-0846 blocks TGF-β signaling pathway by inhibiting SMAD2/3 phosphorylation and nuclear translocation [2].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-124745
CAS No.: 1228280-29-2
Purity:  99.88%
Target:  

MAP4K Wnt Apoptosis

Research Areas:  

Cancer

KY-05009 is an ATP-competitive Traf2- and Nck-interacting kinase (TNIK) inhibitor with a Ki of 100 nM. KY-05009 pharmacologically inhibits TGF-β1-induced epithelial-to-mesenchymal transition (EMT) in human lung adenocarcinoma cells. KY-05009 inhibits the protein expression of TNIK and transcriptional activity of Wnt target genes and induces apoptosis in cancer cells. KY-05009 exerts anti-cancer activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-134050
CAS No.: 2559703-06-7
Purity:  99.84%
Synonyms: Apt-1
Apostatin-1 (Apt-1) is a potent TRADD inhibitor. Apostatin-1 can bind with TRADD-N (KD=2.17 μM), disrupting its binding to both TRADD-C and TRAF2. Apostatin-1 modulates the ubiquitination of RIPK1 and beclin 1. Apostatin-1 blocks apoptosis and restores cellular homeostasis by activating autophagy in cells with accumulated mutant tau, α-synuclein, or huntingtin .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-138779
CAS No.: 1803605-68-6
Purity:  99.25%
Research Areas:  

Inflammation/Immunology

ICCB-19 hydrochloride is a TRADD (TNFRSF1A associated via death domain) inhibitor. ICCB-19 hydrochloride binds with N-terminal domain of TRADD (TRADD-N), disrupting its binding to both TRADD-C and TRAF2. ICCB-19 hydrochloride is indirect inhibitor of RIPK1 kinase activity. ICCB-19 hydrochloride effectively induces autophagy and the degradation of long-lived proteins .
loading...
    loading...
Cat. No.: HY-117469
CAS No.: 193957-88-9
Purity:  95.44%
Triptohypol C, a Tripterin (HY-13067) derivative, is a potent Nur77-targeting anti-inflammatory agent with an Kd value of 0.87 μM. Triptohypol C inhibits inflammatory response by promoting the interactions of Nur77 with TRAF2 and p62/SQSTM1 .
loading...
    loading...
Cat. No.: HY-153598
CAS No.: 2782022-40-4
Research Areas:  

Inflammation/Immunology Cancer

LD4172 is a selective RIPK1 PROTAC degrader with a Ki of 4.8 nM. LD4172 induces RIPK1 protein degradation via ternary complex formation with RIPK1 and VHL E3 ligase, driving ubiquitination and proteasomal breakdown. LD4172 abrogates TNF-induced classical NF-κB signaling in TRAF2-deficient cells, impairing IκBα phosphorylation and degradation, and reducing IL-8 production. LD4172 induces apoptosis and immunogenic cell death in tumor cells, enhances tumor-infiltrating lymphocyte responses, and sensitizes tumors to anti-PD1 therapy. LD4172 acts as a chemical probe for investigating RIPK1 scaffolding functions. LD4172 can be used for the research of melanoma, colon cancer [2].
loading...
    loading...
Cat. No.: HY-124762
CAS No.: 933886-36-3
Purity:  98.86%
Target:  

Ser/Thr Protease

Research Areas:  

Cancer

TNIK-IN-1 (Compound 1) is an inhibitor of Traf2 and Nck-interacting kinase (TNIK), with IC50 of 65 nM, that has antitumor activity .
loading...
    loading...
Cat. No.: HY-156818
CAS No.: 1417795-24-4
Purity:  99.90%
Target:  

Ser/Thr Protease

Research Areas:  

Cancer

TNIK-IN-7 (Compound 8) is an inhibitor of Traf2 and Nck-interacting kinase (TNIK), with IC50 of 11 nM, that has antitumor activity .
loading...
    loading...
Cat. No.: HY-122805
CAS No.: 2056111-45-4
Purity:  99.19%
Target:  

Ser/Thr Protease

Research Areas:  

Neurological Disease

PF-794 is a potent, selective and ATP-competitive Traf2- and Nck-interacting kinase (TNIK) inhibitor with an IC50 of 39 nM. PF-794 shows selective for the TNIK family. PF-794 reduces endogenous p120-catenin phosphorylation in cells. PF-794 can be used for teh study of psychiatric disorders .
loading...
    loading...
Cat. No.: HY-145293
CAS No.: 2754265-25-1
Purity:  99.88%
Target:  

DAPK

Research Areas:  

Cancer

TNIK-IN-3 is a potent, selective and orally active inhibitor of Traf2- and Nck-interacting protein kinase (TNIK), with an IC50 of 0.026 μM. TNIK-IN-3 could also inhibit Flt4 (IC50=0.030 μM), Flt1 (IC50=0.191 μM) and DRAK1 (IC50=0.411 μM). TNIK-IN-3 can be used for the research of colorectal cancer .
loading...
    loading...
Cat. No.: HY-RS14968
Research Areas:  

Others

TRAF2 Human Pre-designed siRNA Set A contains three designed siRNAs for TRAF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-156817
CAS No.: 2375196-40-8
Purity:  96.92%
Target:  

TNF Receptor

Research Areas:  

Neurological Disease

TNIK-IN-6 (Compound 9) is an inhibitor of Traf2 and Nck-interacting kinase (TNIK) and , with IC50 of 0.93 μM, that plays important roles in neurological and psychiatric disorders [2].
loading...
    loading...
Cat. No.: HY-100830A
CAS No.: 2749881-54-5
Target:  

Wnt MAP4K TGF-beta/Smad

Research Areas:  

Inflammation/Immunology

NCB-0970 is the negative control of NCB-0846 (HY-100830). NCB-0846 is an orally active, selective inhibitor for Wnt, that inhibits Traf2- and Nck-interacting kinase (TNIK) with an IC50 of 21 nM. NCB-0846 blocks TGF-β signaling pathway by inhibiting SMAD2/3 phosphorylation and nuclear translocation [2].
loading...
    loading...
Cat. No.: HY-RS16859
Research Areas:  

Others

Traf2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Traf2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS23300
Research Areas:  

Others

Traf2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Traf2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-145292
CAS No.: 2754265-76-2
Purity:  99.68%
Target:  

Ser/Thr Protease

Research Areas:  

Cancer

TNIK-IN-2 is a Traf2- and Nck-interacting protein kinase (TNIK) inhibitor, with an IC50 of 1.3337 μM. TNIK-IN-2 can be used for the study of colorectal cancer (CRC) .
loading...
    loading...
Cat. No.: HY-156502
CAS No.: 1417795-25-5
Purity:  98.02%
Target:  

MAP4K

Research Areas:  

Cancer

TINK-IN-1 (Compound 9) is a potent and selective Traf2- and Nck-interacting kinase (TNIK) inhibitor with an IC50 of 8 nM. TINK-IN-1 inhibits colorectal cancer cells viability .
loading...
    loading...
Cat. No.: HY-174514
Target:  

mRNA

Research Areas:  

Cancer

Human TNFRSF4 mRNA encodes the human TNF receptor superfamily member 4 (TNFRSF4) protein, a member of the TNF receptor superfamily. TNFRSF4 has been shown to activate NF-kappaB through its interaction with adaptor proteins TRAF2 and TRAF5.
loading...
    loading...